Conmed (CNMD) Tops Q4 EPS by 8c, Offers Guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $35.95 +4.02%
EPS Growth %: -3.5%
Financial Fact:
Net Income Basic: 0.26
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: -3.5%
Financial Fact:
Net Income Basic: 0.26
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q4 EPS of $0.84, $0.08 better than the analyst estimate of $0.76. Revenue for the quarter came in at $252.8 million versus the consensus estimate of $262.94 million.
GUIDANCE:
Conmed sees FY2021 EPS of $2.85-$3.05, versus the consensus of $3.02. Conmed sees FY2021 revenue of $975-1020 million, versus the consensus of $1020 million.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
- American Outdoor Brands (AOUT) Tops Q4 EPS by 14c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
